BIOMAT Database Logo BIOMAT Database Logo

Aspartame ingestion with and without carbohydrate in phenylketonuric and normal subjects: effect on plasma concentrations of amino acids, glucose, and insulin. 1990

L C Wolf-Novak, and L D Stegink, and M C Brummel, and T J Persoon, and L J Filer, and E F Bell, and E E Ziegler, and W L Krause
Department of Pediatrics, University of Iowa College of Medicine, Iowa City.

Seven subjects homozygous for phenylketonuria (PKU) and seven normal subjects were administered four beverage regimens after an overnight fast: unsweetened beverage, beverage providing carbohydrate (CHO), beverage providing aspartame (APM), and beverage providing APM plus CHO. The APM dose (200 mg) was the amount provided in 12 oz of diet beverage; the CHO was partially hydrolyzed starch (60 g). Plasma amino acid concentrations were determined after dosing and the molar plasma phenylalanine (Phe) to large neutral amino acid (LNAA) ratio calculated. APM administration without CHO did not increase plasma Phe concentrations over baseline values in either normal or PKU subjects (5.48 +/- 0.85 and 150 +/- 23.0 mumols/dL, respectively). Similarly, the Phe/LNAA did not increase significantly. Ingestion of beverage providing APM and CHO did not significantly increase plasma Phe concentrations over baseline values in either normal or PKU subjects. However, ingestion of beverage providing CHO (with or without APM) significantly decreased plasma levels of valine, isoleucine, and leucine 1.5 to 4 hours after dosing in both normal and PKU subjects, thereby increasing the Phe/LNAA ratio significantly. These data indicate that changes noted in Phe/LNAA values after ingestion of beverage providing APM plus CHO were due to CHO. The plasma insulin response to beverage providing CHO (with or without APM) was significantly higher in PKU subjects than in normals.

UI MeSH Term Description Entries
D007328 Insulin A 51-amino acid pancreatic hormone that plays a major role in the regulation of glucose metabolism, directly by suppressing endogenous glucose production (GLYCOGENOLYSIS; GLUCONEOGENESIS) and indirectly by suppressing GLUCAGON secretion and LIPOLYSIS. Native insulin is a globular protein comprised of a zinc-coordinated hexamer. Each insulin monomer containing two chains, A (21 residues) and B (30 residues), linked by two disulfide bonds. Insulin is used as a drug to control insulin-dependent diabetes mellitus (DIABETES MELLITUS, TYPE 1). Iletin,Insulin A Chain,Insulin B Chain,Insulin, Regular,Novolin,Sodium Insulin,Soluble Insulin,Chain, Insulin B,Insulin, Sodium,Insulin, Soluble,Regular Insulin
D007700 Kinetics The rate dynamics in chemical or physical systems.
D008297 Male Males
D010661 Phenylketonurias A group of autosomal recessive disorders marked by a deficiency of the hepatic enzyme PHENYLALANINE HYDROXYLASE or less frequently by reduced activity of DIHYDROPTERIDINE REDUCTASE (i.e., atypical phenylketonuria). Classical phenylketonuria is caused by a severe deficiency of phenylalanine hydroxylase and presents in infancy with developmental delay; SEIZURES; skin HYPOPIGMENTATION; ECZEMA; and demyelination in the central nervous system. (From Adams et al., Principles of Neurology, 6th ed, p952). Biopterin Deficiency,Dihydropteridine Reductase Deficiency Disease,Hyperphenylalaninemia, Non-Phenylketonuric,Phenylalanine Hydroxylase Deficiency Disease,BH4 Deficiency,DHPR Deficiency,Deficiency Disease, Dihydropteridine Reductase,Deficiency Disease, Phenylalanine Hydroxylase,Deficiency Disease, Phenylalanine Hydroxylase, Severe,Dihydropteridine Reductase Deficiency,Folling Disease,Folling's Disease,HPABH4C,Hyperphenylalaninaemia,Hyperphenylalaninemia Caused by a Defect in Biopterin Metabolism,Hyperphenylalaninemia, BH4-Deficient, C,Hyperphenylalaninemia, Tetrahydrobiopterin-Deficient, Due To DHPR Deficiency,Non-Phenylketonuric Hyperphenylalaninemia,Oligophrenia Phenylpyruvica,PAH Deficiency,PKU, Atypical,Phenylalanine Hydroxylase Deficiency,Phenylalanine Hydroxylase Deficiency Disease, Severe,Phenylketonuria,Phenylketonuria I,Phenylketonuria II,Phenylketonuria Type 2,Phenylketonuria, Atypical,Phenylketonuria, Classical,QDPR Deficiency,Quinoid Dihydropteridine Reductase Deficiency,Tetrahydrobiopterin Deficiency,Atypical PKU,Atypical Phenylketonuria,Biopterin Deficiencies,Classical Phenylketonuria,Deficiency, BH4,Deficiency, Biopterin,Deficiency, DHPR,Deficiency, Dihydropteridine Reductase,Deficiency, PAH,Deficiency, Phenylalanine Hydroxylase,Deficiency, QDPR,Deficiency, Tetrahydrobiopterin,Disease, Folling,Disease, Folling's,Hyperphenylalaninemia, Non Phenylketonuric,Non Phenylketonuric Hyperphenylalaninemia,Non-Phenylketonuric Hyperphenylalaninemias
D012016 Reference Values The range or frequency distribution of a measurement in a population (of organisms, organs or things) that has not been selected for the presence of disease or abnormality. Normal Range,Normal Values,Reference Ranges,Normal Ranges,Normal Value,Range, Normal,Range, Reference,Ranges, Normal,Ranges, Reference,Reference Range,Reference Value,Value, Normal,Value, Reference,Values, Normal,Values, Reference
D001786 Blood Glucose Glucose in blood. Blood Sugar,Glucose, Blood,Sugar, Blood
D004032 Diet Regular course of eating and drinking adopted by a person or animal. Diets
D004151 Dipeptides Peptides composed of two amino acid units. Dipeptide
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

L C Wolf-Novak, and L D Stegink, and M C Brummel, and T J Persoon, and L J Filer, and E F Bell, and E E Ziegler, and W L Krause
Repeated ingestion of aspartame-sweetened beverage: effect on plasma amino acid concentrations in normal adults.
March 1988, Metabolism: clinical and experimental,
L C Wolf-Novak, and L D Stegink, and M C Brummel, and T J Persoon, and L J Filer, and E F Bell, and E E Ziegler, and W L Krause
Effect of elevated plasma phenylalanine levels on other amino acids in phenylketonuric and normal subjects.
March 1969, The Journal of pediatrics,
L C Wolf-Novak, and L D Stegink, and M C Brummel, and T J Persoon, and L J Filer, and E F Bell, and E E Ziegler, and W L Krause
Effect of aspartame loading upon plasma and erythrocyte amino acid levels in phenylketonuric heterozygotes and normal adult subjects.
April 1979, The Journal of nutrition,
L C Wolf-Novak, and L D Stegink, and M C Brummel, and T J Persoon, and L J Filer, and E F Bell, and E E Ziegler, and W L Krause
Effect of dietary aspartame on plasma concentrations of phenylalanine and tyrosine in normal and homozygous phenylketonuric patients.
July 1992, Clinical pediatrics,
L C Wolf-Novak, and L D Stegink, and M C Brummel, and T J Persoon, and L J Filer, and E F Bell, and E E Ziegler, and W L Krause
Effect of an abuse dose of aspartame upon plasma and erythrocyte levels of amino acids in phenylketonuric heterozygous and normal adults.
November 1980, The Journal of nutrition,
L C Wolf-Novak, and L D Stegink, and M C Brummel, and T J Persoon, and L J Filer, and E F Bell, and E E Ziegler, and W L Krause
Aspartame metabolism in normal adults, phenylketonuric heterozygotes, and diabetic subjects.
January 1989, Diabetes care,
L C Wolf-Novak, and L D Stegink, and M C Brummel, and T J Persoon, and L J Filer, and E F Bell, and E E Ziegler, and W L Krause
Effect of repeated ingestion of aspartame-sweetened beverage on plasma amino acid, blood methanol, and blood formate concentrations in normal adults.
April 1989, Metabolism: clinical and experimental,
L C Wolf-Novak, and L D Stegink, and M C Brummel, and T J Persoon, and L J Filer, and E F Bell, and E E Ziegler, and W L Krause
Plasma alanine and lactate concentrations following glucose ingestion in normal and NIDDM subjects.
January 1992, Diabetes research (Edinburgh, Scotland),
L C Wolf-Novak, and L D Stegink, and M C Brummel, and T J Persoon, and L J Filer, and E F Bell, and E E Ziegler, and W L Krause
Repeated ingestion of aspartame-sweetened beverage: effect on plasma amino acid concentrations in individuals heterozygous for phenylketonuria.
January 1989, Metabolism: clinical and experimental,
L C Wolf-Novak, and L D Stegink, and M C Brummel, and T J Persoon, and L J Filer, and E F Bell, and E E Ziegler, and W L Krause
Effect of aspartame and protein, administered in phenylalanine-equivalent doses, on plasma neutral amino acids, aspartate, insulin and glucose in man.
May 1991, Pharmacology & toxicology,
Copied contents to your clipboard!